In addition, topical IFN-γ (IFN-γ 1b) was tested for treating cystoid macular edema (CME) secondary to uveitis, and it seemed to improve the CME (Clinicaltrials.gov NCT01376362). The gene discussed is IFNG; the disease is Cystoid macular dystrophy.